Category Archives: Pr Newswire

VYNE Therapeutics to Participate in Leerink Partners Therapeutics Forum

Boston event to focus on Immunology & Inflammation (I&I) and Metabolic Diseases BRIDGEWATER, N.J., June 26, 2024 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced members of VYNE’s management will participate in one-on-one […]

Leading Companies in the Retail and Consumer Goods Industries Support the Transition to QR Codes with GS1 Standards

50 years after the barcode was first scanned, 22 leaders from the world’s biggest companies sign a global joint statement calling for the transition to QR Codes with GS1 standards to revolutionise the consumer experience Signatories include industry champions like Alibaba.com, AS Watson, Carrefour, IGA, JD.com, JM Smucker, Mondelēz, Lidl, L’Oréal, Nestlé, P&G, and Savencia […]

Zhihu Inc. Announces Results of the Annual General Meeting

BEIJING, June 26, 2024 /PRNewswire/ — Zhihu Inc. (NYSE: ZH; HKEX: 2390) (“Zhihu” or the “Company”), a leading online content community in China, today announced that each of the proposed resolutions submitted for shareholders’ approval (the “Proposed Resolutions”) as set forth in the notice of annual general meeting dated May 30, 2024 (the “AGM Notice”) has […]

Hygenco and Ameropa ink cooperation for supply of Green Ammonia

BASEL, Switzerland, June 26, 2024 /PRNewswire/ — Hygenco Green Energies and Ameropa, have signed a Term Sheet in view of the potential supply of green ammonia from Hygenco’s planned Green Ammonia plant in India. This aims at enhancing green ammonia exports from India, supporting the global transition to renewable energy and sustainable agricultural practices. Hygenco signs term […]

Shell to build carbon capture and storage projects in Canada

CALGARY, AB, June 26, 2024 /PRNewswire/ — Shell Canada Products, a subsidiary of Shell plc, today announced the Final Investment Decision (FID) for Polaris, a carbon capture project at the Shell Energy and Chemicals Park, Scotford in Alberta, Canada. Polaris is designed to capture approximately 650,000 tonnes of CO2 annually from the Shell-owned Scotford refinery and […]

MWCS 2024: Huawei Embraces Commercial 5G-A for the Mobile AI Era

SHANGHAI, June 26, 2024 /PRNewswire/ — Huawei is attending MWC Shanghai 2024 under the banner of “Advancing the Intelligent World” and offering “Commercial 5G-A Experience Tours”. At its booth in SNIEC Hall N1, Huawei is showcasing its latest products and solutions that support both commercial 5G-A deployment and AI devices required for the mobile AI […]

Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary shares raising gross proceeds of USD 1 billion / DKK 7 billion

Company announcement – No. 35 / 2024 Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary shares raising gross proceeds of USD 1 billion / DKK 7 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH […]

Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

DALLAS, June 25, 2024 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that it has commenced an underwritten public offering of up to $75 million of shares of its common […]

Appili Therapeutics Reports Fiscal Year 2024 Financial and Operational Results

LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL launched and commercial sales ongoing Funding commitments from U.S. Air Force Academy intended to advance ATI-1701 toward an IND submission to the FDA Engaging regulatory authorities to align on ATI-1801 development plans  HALIFAX, Nova Scotia, June 25, 2024 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” […]

Fennec Announces Results of Annual Meeting

RESEARCH TRIANGLE PARK, N.C., June 25, 2024 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 29, 2024 (the “Circular”) for the Annual General Meeting of Shareholders were elected as directors of the Company at the Annual General Meeting of Shareholders […]